HNRNPDLP3

Across TCGA pan-cancer cohorts, HNRNPDLP3 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated HNRNPDLP3 data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher HNRNPDLP3 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated HNRNPDLP3 expression acts as an unfavorable survival marker.

HNSC, BRCA, and KIRC are the cancer types where HNRNPDLP3 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	All	0.010	0.768	<.001	87	view →
BRCA	OS	Tertile	III,IV	0.233	0.833	<.001	36	view →
KIRC	DFS	Tertile	IV	0.160	0.624	.003	36	view →
OV	DFS	Tertile	III,IV	0.083	0.534	<.001	30	view →
UCS	OS	Tertile	All	0.185	0.686	.034	18	view →
LIHC	OS	Tertile	All	0.147	0.564	.011	18	view →
KIRP	OS	Tertile	II,III,IV	0.199	0.771	.030	12	view →
SKCM	OS	Tertile	II,III,IV	0.220	0.739	.007	9	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

HNRNPDLP3–HNSC (OS)

Open the HNSC breakdown →